Back to Search
SHEIDA MANI MD
MD
Radiation Oncology Physician
NPI: 1154319150IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
1022276(MA)
Education
OTHER
Class of 1996
Research & Publications (20)
Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions.
PMID 19239394·Expert Opin Drug Metab Toxicol·2009
6-review
Steroid hormone action in the brain: cross-talk between signalling pathways.
PMID 19187467·J Neuroendocrinol·2009
6-review
Progestin receptor subtypes in the brain: the known and the unknown.
PMID 18308838·Endocrinology·2008
6-review
The epithelial-mesenchymal transition generates cells with properties of stem cells.
PMID 18485877·Cell·2008
7-preclinical
Comparison of two methods of dental age estimation in 7-15-year-old Malays.
PMID 18284472·Int J Paediatr Dent·2008
4-observational
Learning causal and predictive clinical practice guidelines from data.
PMID 17911836·Stud Health Technol Inform·2007
8-other
Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone.
PMID 17018704·Ann Oncol·2007
3-trial
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.
PMID 17537911·Proc Natl Acad Sci U S A·2007
4-observational
In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus.
PMID 16412227·BMC Complement Altern Med·2006
7-preclinical
Differential response of progesterone receptor isoforms in hormone-dependent and -independent facilitation of female sexual receptivity.
PMID 16484336·Mol Endocrinol·2006
4-observational
On call for the duration: code gray: a resident's personal account from Children's Hospital of New Orleans.
PMID 16735270·Pediatrics·2006
8-other
Signaling mechanisms in progesterone-neurotransmitter interactions.
PMID 16310962·Neuroscience·2006
6-review
Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents.
PMID 16144941·Clin Cancer Res·2005
7-preclinical
Causal discovery using a Bayesian local causal discovery algorithm.
PMID 15360909·Stud Health Technol Inform·2004
8-other
The clinical development of new mitotic inhibitors that stabilize the microtubule.
PMID 15205596·Anticancer Drugs·2004
6-review
Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors.
PMID 14977827·Clin Cancer Res·2004
3-trial
Signalling mechanisms in progesterone-neurotransmitter interactions.
PMID 12683937·J Mol Endocrinol·2003
6-review
Emerging concepts in the regulation of female sexual behavior.
PMID 12914586·Scand J Psychol·2003
6-review
Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.
PMID 14751840·Ann N Y Acad Sci·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via CENTRAL MASSACHUSETTS COMPREHENSIVE CANCER CENTER LLC · 2 locations total
- Address
- 55 SAYLES ST
SOUTHBRIDGE, MA 01550 - Phone
- (508) 765-6830
Quick Facts
- NPI
- 1154319150
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile